Spots Global Cancer Trial Database for ros1 positive
Every month we try and update this database with for ros1 positive cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
PF-06463922 for Crizotinib Pretreated ROS1 Positive Non-small-cell Lung Cancer | NCT03439215 | Carcinoma, Non-... | Lorlatinib | 18 Years - | Fondazione Ricerca Traslazionale | |
Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC | NCT01945021 | Non Small Cell ... ROS1 Proto Onco... Crizotinib | Crizotinib | 18 Years - | Pfizer |